On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
On Oct. 15, 2021, Pfizer and BioNTech announced they had submitted data supporting the vaccination of children 5…
On Oct. 14, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) has accepted for priority…
On Oct. 13, 2021, the World Health Organization (WHO) honoured the late Henrietta Lacks with a WHO Director-General’s…
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use…
On Oct. 6, 2021, Vaxart announced that it had begun recruiting subjects for its Phase II COVID-19 oral…
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
On Oct. 6, 2021, Lumen Bioscience announced new development funding from the US Army for its Covid-19 monoclonal…
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
On Oct. 1, 2021, Merck and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…
On Oct. 1, 2021, Kite, a Gilead Company, announced the U.S. Food and Drug Administration (FDA) has granted…
On Sept. 30, 2021, Trevena announced data from 30 patients enrolled in the proof-of-concept study of TRV027, the…
This cartoon illustrates the various issues facing individuals across the U.S. who are vaccinated against COVID-19 verus those…
On Sept. 29, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) published positive detailed results…
On Sept. 29, 2021, Roche confirmed positive data from the phase II/III 2066 study, investigating Ronapreveﾙ (casirivimab and…
On Sept. 28, 2021, the University of Arizona has been awarded a five-year $60 million grant from the…
On Sept. 28, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 28, 2021, Soligenix announced publication of pre-clinical immunogenicity studies for CiVax (heat stable COVID-19 vaccine program)…
On Sept. 27, 2021, Pfizer announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for…
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
On Sept. 23, 2021, Tonix Pharmaceuticals announced it had expanded its research collaboration with Columbia University. The research…
On Sept. 22, 2021, Gilead Sciences announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…